transition from tirzepatide to semaglutide TrimRX Switching from Semaglutide to Tirzepatide:

Tirzepatides dual receptor targeting initially raised questions about whether activating multiple pathways might increase adverse event risk

This dual action means tirzepatide sends hunger-suppressing signals through two separate channels in the brain and body

In the body, IGF-1 can activate growth a multitude of bodily tissues, including the nerves, bone, kidneys, and liver

Although tirzepatide does not directly interact with estrogen or progestin, there is a possibility that its effects on hormone-regulated processes, like metabolism, could have indirect effects on hormonal birth control

It is important to understand that semaglutide and tirzepatide have active patents on their original component